CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 97 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,574,000 | -50.9% | 152,964 | -51.7% | 0.02% | -48.3% |
| Q3 2016 | $3,205,000 | -39.3% | 316,976 | -32.6% | 0.03% | -47.3% |
| Q2 2016 | $5,279,000 | -22.1% | 470,058 | -5.2% | 0.06% | -22.5% |
| Q1 2016 | $6,774,000 | -28.0% | 495,908 | 0.0% | 0.07% | -9.0% |
| Q4 2015 | $9,407,000 | +1.1% | 495,908 | 0.0% | 0.08% | -9.3% |
| Q3 2015 | $9,308,000 | +26.1% | 495,908 | 0.0% | 0.09% | +32.3% |
| Q2 2015 | $7,384,000 | -1.7% | 495,908 | 0.0% | 0.06% | +4.8% |
| Q1 2015 | $7,511,000 | +11.6% | 495,908 | -1.9% | 0.06% | -10.1% |
| Q4 2014 | $6,732,000 | +18.3% | 505,418 | +11.9% | 0.07% | -4.2% |
| Q3 2014 | $5,693,000 | +41.3% | 451,496 | +13.2% | 0.07% | +46.9% |
| Q2 2014 | $4,028,000 | – | 398,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |